Published in Arch Neurol on May 01, 2004
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology (2005) 4.04
Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology (2008) 2.97
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci (2009) 2.86
Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev (2008) 2.62
Education and rates of cognitive decline in incident Alzheimer's disease. J Neurol Neurosurg Psychiatry (2006) 2.29
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord (2007) 2.24
Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13
Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol (2010) 1.91
Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol (2008) 1.88
Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol (2009) 1.86
The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology (2010) 1.64
Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature. Alzheimer Dis Assoc Disord (2009) 1.64
The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm (2010) 1.59
Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care (2008) 1.52
Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch Arztebl Int (2011) 1.43
Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol (2011) 1.42
Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther (2012) 1.30
The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol Aging (2010) 1.25
Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease. J Biol Chem (2010) 1.20
Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol (2011) 1.17
Coronary risk correlates with cerebral amyloid deposition. Neurobiol Aging (2011) 1.17
Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. J Neurosci (2012) 1.16
Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord (2007) 1.16
Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement (2012) 1.15
The effects of cardiovascular risk factors on cognitive compromise. Dialogues Clin Neurosci (2009) 1.13
Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study. J Stroke Cerebrovasc Dis (2011) 1.12
Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia. Curr Psychiatry Rev (2009) 1.09
Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders. Age Ageing (2008) 1.07
Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol (2014) 1.05
The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer. Cholesterol (2010) 1.03
Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment. Dement Geriatr Cogn Disord (2008) 1.03
Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics (2011) 0.97
Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease. BMC Med (2009) 0.94
Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease. J Neurol Sci (2007) 0.92
Small vessel versus large vessel vascular dementia: risk factors and MRI findings. J Neurol (2008) 0.91
Alcohol effects on cognitive change in middle-aged and older adults. Aging Ment Health (2012) 0.88
Apolipoprotein E pathology in vascular dementia. Int J Clin Exp Pathol (2014) 0.87
Vascular dementia: prevention and treatment. Clin Interv Aging (2006) 0.87
Dementia in the oldest old. Nat Rev Neurol (2013) 0.86
Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain. PLoS One (2015) 0.85
Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years. Eur Arch Psychiatry Clin Neurosci (2013) 0.85
Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations. J Alzheimers Dis (2012) 0.85
A comparison of cardiovascular disease risk factor biomarkers in African Americans and Yoruba Nigerians. Ethn Dis (2008) 0.85
Dyslipidemia and the risk of Alzheimer's disease. Curr Atheroscler Rep (2013) 0.85
Sex differences in the associations between lipid levels and incident dementia. J Alzheimers Dis (2013) 0.85
Comparison between Complementary Dietary Treatment of Alzheimer Disease in Iranian Traditional Medicine and Modern Medicine. Iran J Public Health (2013) 0.85
HDL and cognition in neurodegenerative disorders. Neurobiol Dis (2014) 0.84
Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I? Am J Epidemiol (2007) 0.83
Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study. J Gerontol A Biol Sci Med Sci (2010) 0.83
Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway. J Biol Chem (2014) 0.83
Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways. Neurobiol Aging (2013) 0.83
Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease. Lipids Health Dis (2012) 0.83
Decreased serum lipids in patients with probable Alzheimer's disease. Bosn J Basic Med Sci (2009) 0.82
Non-pharmacologic prevention of Alzheimer's disease: nutritional and life-style risk factors. J Neural Transm (Vienna) (2007) 0.82
Baseline serum cholesterol is selectively associated with motor speed and not rates of cognitive decline: the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci (2008) 0.82
Links between copper and cholesterol in Alzheimer's disease. Front Physiol (2013) 0.81
Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan. PLoS One (2014) 0.80
Effects of exercise intervention on vascular risk factors in older adults with mild cognitive impairment: a randomized controlled trial. Dement Geriatr Cogn Dis Extra (2012) 0.79
ApoA-I/HDL Generation and Intracellular Cholesterol Transport through Cytosolic Lipid-Protein Particles in Astrocytes. J Lipids (2014) 0.78
A review of the potential therapeutic role of statins in the treatment of Alzheimer's disease: current research and opinion. Neuropsychiatr Dis Treat (2013) 0.78
Cardiovascular prevention of cognitive decline. Cardiol Res Pract (2011) 0.78
Dietary Factors and Cognitive Decline. J Prev Alzheimers Dis (2016) 0.78
Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender. Dement Geriatr Cogn Disord (2014) 0.77
Circulating biomarkers that predict incident dementia. Alzheimers Res Ther (2014) 0.77
The relationship between cholesterol and cognitive function is homocysteine-dependent. Clin Interv Aging (2014) 0.77
Elevated levels of serum cholesterol are associated with better performance on tasks of episodic memory. Metab Brain Dis (2016) 0.77
Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients. Front Aging Neurosci (2016) 0.76
Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study. PLoS Med (2017) 0.75
Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis. J Alzheimers Dis (2016) 0.75
Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status. Int J Environ Res Public Health (2014) 0.75
Association between APOE ε4 Genotype and Memory Impairment in Elderly with Normal Global Cognitive Assessment. Diagnostics (Basel) (2015) 0.75
Statins Reduces the Risk of Dementia in Patients with Late-Onset Depression: A Retrospective Cohort Study. PLoS One (2015) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res (1990) 14.82
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol (2000) 8.07
The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA (1998) 7.81
Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ (1976) 7.43
Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem (1977) 5.09
Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol (1992) 4.63
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology (1995) 3.91
Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology (1995) 2.99
Cholesterol metabolism in the brain. Curr Opin Lipidol (2001) 2.94
High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA (2001) 2.85
Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey. J Am Geriatr Soc (2001) 2.70
Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ (1994) 2.60
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension (2001) 1.84
Bias in the evaluation of low-magnitude associations: an empirical perspective. Am J Epidemiol (2000) 1.76
Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem Biophys Res Commun (1998) 1.72
Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology (1992) 1.61
Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA (1999) 1.42
Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci Lett (1988) 1.38
Effects of lovastatin on cognitive function and psychological well-being. Am J Med (2000) 1.32
The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J Gerontol A Biol Sci Med Sci (2002) 1.32
Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease? J Neurosci Res (2003) 1.29
Cholesterol in Alzheimer's disease and tauopathy. Ann N Y Acad Sci (2002) 1.23
Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol (2002) 1.21
Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1994) 1.19
Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease. Dement Geriatr Cogn Disord (2001) 1.15
Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Neurosci Lett (2002) 1.06
DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 0.96
High-density lipoprotein cholesterol in differential diagnosis of senile dementia. Lancet (1985) 0.96
Involvement of lipid peroxidation in CNS injury. J Neurotrauma (1992) 0.96
Low levels of serum apolipoprotein A I and A II in senile dementia. Jpn J Psychiatry Neurol (1994) 0.95
Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci (2002) 0.94
[Serum lipids, lipoproteins and apolipoproteins in patients with senile dementia]. Nihon Ronen Igakkai Zasshi (1992) 0.90
Apolipoprotein E genotypes and serum lipid levels in Alzheimer's disease and multi-infarct dementia. Int J Geriatr Psychiatry (1997) 0.88
Paraoxonase 1 activity: a new vascular marker of dementia? Ann N Y Acad Sci (2002) 0.87
Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma. Stroke (2001) 0.86
Plasma antioxidant activity and vascular dementia. J Neurol Sci (2002) 0.86
Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease. BMC Geriatr (2001) 0.84
Preliminary results from an MRI/CT-based database for vascular dementia and Alzheimer's disease. Ann N Y Acad Sci (2000) 0.84
Increased low-density lipoprotein peroxidation in elderly men. Coron Artery Dis (1997) 0.82
[Vascular dementia and systemic changes]. Przegl Lek (2002) 0.81
New possible role of statins in age-related diseases. J Am Geriatr Soc (2002) 0.79
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Apolipoprotein E, Alzheimer disease, and African Americans. Arch Neurol (2003) 4.63
Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38
Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13
Hypertension and the risk of mild cognitive impairment. Arch Neurol (2007) 3.62
A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52
Stroke and the risk of Alzheimer disease. Arch Neurol (2003) 3.49
Mediterranean diet and mild cognitive impairment. Arch Neurol (2009) 3.40
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
Imaging hippocampal function across the human life span: is memory decline normal or not? Ann Neurol (2002) 3.34
Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One (2012) 3.11
Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol (2006) 2.98
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91
Alcohol intake and risk of dementia. J Am Geriatr Soc (2004) 2.90
Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord (2005) 2.88
Hyperinsulinemia and risk of Alzheimer disease. Neurology (2004) 2.87
Relation of diabetes to mild cognitive impairment. Arch Neurol (2007) 2.86
Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology (2005) 2.76
Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol (2008) 2.69
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Mediterranean diet and Alzheimer disease mortality. Neurology (2007) 2.45
Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol (2005) 2.39
Caloric intake and the risk of Alzheimer disease. Arch Neurol (2002) 2.28
Literacy and memory decline among ethnically diverse elders. J Clin Exp Neuropsychol (2003) 2.27
Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet (2012) 2.23
The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol (2007) 2.21
Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol (2006) 2.21
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol (2012) 2.20
Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol (2003) 2.20
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron (2013) 2.13
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol (2009) 2.06
Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol (2009) 2.05
Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet (2011) 2.02
SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann Neurol (2011) 2.01
Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep (2004) 2.00
Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Arch Neurol (2012) 1.97
Albuminuria and dementia in the elderly: a community study. Am J Kidney Dis (2008) 1.96
The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Ann Neurol (2008) 1.92
Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol (2010) 1.91
Dietary factors and Alzheimer's disease. Lancet Neurol (2004) 1.90
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) (2012) 1.90
Measures of adiposity and dementia risk in elderly persons. Arch Neurol (2007) 1.88
Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci U S A (2008) 1.84
Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol (2010) 1.80
Disparities in the recording of Parkinson's disease on death certificates. Mov Disord (2005) 1.75
Health and function of participants in the Long Life Family Study: A comparison with other cohorts. Aging (Albany NY) (2011) 1.74
Stroke and memory performance in elderly persons without dementia. Arch Neurol (2006) 1.65
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet (2012) 1.63
Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol (2010) 1.61
Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol (2011) 1.59
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58
Association between SORL1 and Alzheimer's disease in a genome-wide study. Neuroreport (2007) 1.57
Association of shorter leukocyte telomere repeat length with dementia and mortality. Arch Neurol (2012) 1.55
Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord (2002) 1.52
Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol (2013) 1.52
Imaging the Abeta-related neurotoxicity of Alzheimer disease. Arch Neurol (2007) 1.49
Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol (2005) 1.48
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med (2014) 1.45
Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc (2005) 1.44
Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. Arch Neurol (2008) 1.44
Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol (2012) 1.44
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med (2011) 1.44
The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science (2003) 1.40
Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Arch Neurol (2005) 1.39
Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? Neuropsychology (2010) 1.37
Obesity and change in estimated GFR among older adults. Am J Kidney Dis (2009) 1.37
Parkinsonian signs in older people in a community-based study: risk of incident dementia. Arch Neurol (2004) 1.35
C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. JAMA Neurol (2013) 1.34
Investigation of c9orf72 in 4 neurodegenerative disorders. Arch Neurol (2012) 1.32
Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE. Arch Neurol (2002) 1.28
Parkinsonian signs in older people: prevalence and associations with smoking and coffee. Neurology (2003) 1.27
Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol (2007) 1.26
Meta-analysis of plasma amyloid-β levels in Alzheimer's disease. J Alzheimers Dis (2011) 1.25
SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One (2013) 1.23
Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease. Neurogenetics (2007) 1.22
Heritability estimates of endophenotypes of long and health life: the Long Life Family Study. J Gerontol A Biol Sci Med Sci (2010) 1.22
Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Arch Neurol (2010) 1.22